Skip to main content

Apricus Biosciences Aktie - Fundamentalanalyse - Dividendenrendite KGV

Apricus Biosciences (ISIN: US03832V3078, WKN: A2AT45) Kursdatum: 16.11.2017 Kurs: 1,620 USD
Beschreibung Daten
Symbol APRI
Marktkapitalisierung 10.556.989,00 USD
Land Vereinigte Staaten von Amerika
Indizes NASDAQ Comp.
Sektor Gesundheitswesen
Rohdaten nach US GAAP in Millionen USD
Aktiensplits 2016-10-24 - 1:10 | 2010-06-21 - 1:15 |
Internet www.apricusbio.com
Letztes Bilanz Update 13.03.2017

Fundamentaldaten

Fundamental Verhältnisse errechnet am: 16.11.2017
KFCV KCV DIV Rendite GKR EKQ KGV KUV KBV
-0,81 -0,81 0,01% -158,06 -159,91 -1,42 1,83 -1,41

Firmenbeschreibung

SELECTED QUARTERLY FINANCIAL INFORMATION (UNAUDITED)The following table presents the Company’s unaudited quarterly results of operations for the years ended December 31, 2015 and 2014 (in thousands, except per share data):   2015  1st Quarter 2nd Quarter 3rd Quarter 4th QuarterTotal revenue $475 $462 $1,273 $2,629Gross profit (loss) 242 (47) 1,131 2,591Net loss  (6,412) (5,245) (5,034) (2,332)Basic and diluted loss per share  $(0.13) $(0.10) $(0.10) $(0.05)           2014  1st Quarter 2nd Quarter 3rd Quarter 4th QuarterTotal revenue $— $5,454 $1,898 $1,907Gross profit (loss) — 5,379 1,413 1,549(Loss) income from continuing operations (3,262) 1,205 (3,132) (17,288)Income (loss) from discontinued operations  — 672 19 —Net loss (income) (3,262) 1,877 (3,113) (17,288)Basic loss (income) per share         (Loss) income from continuing operations (0.09) 0.03 (0.08) (0.40)Income from discontinued operations  — 0.02 — —Net (loss) income (0.09) 0.05 (0.08) (0.40)Diluted loss (income) per share         (Loss) income from continuing operations (0.09) 0.03 (0.08) (0.40)Income from discontinued operations  — 0.02 — —Net loss $(0.09) $0.05

Die Finanzoo GmbH übernimmt keine Haftung für die Richtigkeit der Angaben! Alle Angaben sind ohne Gewähr. Quellen: www.bundesanzeiger.de, www.sec.gov, www.apricusbio.com